(Q38003068)

26 August 2017

The significance of defining preclinical or prodromal Parkinson's disease (English)

1 reference

26 August 2017

1 reference

Charles Warren Olanow

series ordinal

1

object named as

C Warren Olanow

1 reference

26 August 2017

José A Obeso

2

1 reference

PubMed ID

22508285

26 August 2017

language of work or name

English

0 references

publication date

1 April 2012

1 reference

26 August 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

Movement Disorders

1 reference

26 August 2017

27

1 reference

26 August 2017

5

1 reference

26 August 2017

666-669

1 reference

The scientific and clinical basis for the treatment of Parkinson disease (2009).

26 August 2017

1 reference

What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

21 January 2018

1 reference

Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts

21 January 2018

1 reference

Lewy pathology and neurodegeneration in premotor Parkinson's disease

21 January 2018

1 reference

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

The Parkinson's complex: parkinsonism is just the tip of the iceberg

21 January 2018

1 reference

Motor signs in the prodromal phase of Parkinson's disease

21 January 2018

1 reference

Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease

21 January 2018

1 reference

Biochemical premotor biomarkers for Parkinson's disease

21 January 2018

1 reference

Neuroimaging: current role in detecting pre-motor Parkinson's disease.

21 January 2018

1 reference

Premotor Parkinson's disease: concepts and definitions

21 January 2018

1 reference

Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.

21 January 2018

1 reference

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

21 January 2018

1 reference

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

21 January 2018

1 reference

Is Parkinson's disease a prion disorder?

21 January 2018

1 reference

Defining disease-modifying therapies for PD--a road map for moving forward

21 January 2018

1 reference

Timing of treatment initiation in Parkinson's disease: a need for reappraisal?

21 January 2018

1 reference

Compensatory mechanisms in Parkinson's disease

21 January 2018

1 reference

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease

21 January 2018

1 reference

A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes

21 January 2018

1 reference

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

21 January 2018

1 reference

A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease

21 January 2018

1 reference

A double-blind, delayed-start trial of rasagiline in Parkinson's disease

21 January 2018

1 reference

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.25019

1 reference

release_yps7j2wopnderaqp36xrinudy4

26 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yps7j2wopnderaqp36xrinudy4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

22508285

1 reference

PubMed ID

22508285